The cartridges were reportedly printed using acrylonitrile butadiene styrene (ABS), a robust engineering plastic, in less than 2 hours and with low costs, with the cartridges weighing about 13 grams (similar to a AAA battery) and measuring a few centimetres in size (palm size).
Archer's CEO Dr. Mohammad Choucair said: “Additive manufacturing allows Archer to make prototypes of key biosensor elements in less than a few hours. By using 3D printing we are able to accelerate progress towards commercializing Archer’s innovative graphene-based biosensor technology".
“When the Company undertook the recent Share Purchase Plan the main purpose of the fund raising was to allow the Company to accelerate the pace of development of our key projects and technologies.
“The 3D printing of biosensor components is consistent with that strategy.”
Archer has access to excellent infrastructure, facilities, R&D personnel, and 3D and 2D printers through the company’s collaboration with the University of Adelaide, as a founding industry partner of the ARC Research Hub for Graphene Enabled Industry Transformation (ARC Graphene Hub).
An international patent has now been published by the World Intellectual Property Organization (WIPO) to protect and commercialize intellectual property (IP) associated with the graphene-based biosensor materials technology.